These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 36995652)
21. Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials. Criscuolo E; Diotti RA; Ferrarese R; Alippi C; Viscardi G; Signorelli C; Mancini N; Clementi M; Clementi N Emerg Microbes Infect; 2021 Dec; 10(1):206-210. PubMed ID: 33399524 [TBL] [Abstract][Full Text] [Related]
22. Long-term variability of human health-related solar ultraviolet-B radiation doses for the 1980s to the end of the 21st century. Zerefos C; Fountoulakis I; Eleftheratos K; Kazantzidis A Physiol Rev; 2023 Jul; 103(3):1789-1826. PubMed ID: 36787480 [TBL] [Abstract][Full Text] [Related]
23. Using genetic variants to evaluate the causal effect of serum vitamin D concentration on COVID-19 susceptibility, severity and hospitalization traits: a Mendelian randomization study. Cui Z; Tian Y J Transl Med; 2021 Jul; 19(1):300. PubMed ID: 34246301 [TBL] [Abstract][Full Text] [Related]
24. SARS-CoV-2 Ultraviolet Radiation Dose-Response Behavior. Blatchley Iii ER; Petri B; Sun W J Res Natl Inst Stand Technol; 2021; 126():126018. PubMed ID: 38469447 [TBL] [Abstract][Full Text] [Related]
25. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Akova M; Unal S Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629 [TBL] [Abstract][Full Text] [Related]
26. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial. Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494 [TBL] [Abstract][Full Text] [Related]
27. Ozone potential to fight against SAR-COV-2 pandemic: facts and research needs. Blanco A; Ojembarrena FB; Clavo B; Negro C Environ Sci Pollut Res Int; 2021 Apr; 28(13):16517-16531. PubMed ID: 33389580 [TBL] [Abstract][Full Text] [Related]
28. Estimation of Inactivation time for the SARS-CoV-2 virus from the UV biometer in South Korea. Park SS; Lee YG; Park SJ Air Qual Atmos Health; 2023 May; ():1-17. PubMed ID: 37359390 [TBL] [Abstract][Full Text] [Related]
29. Impact of High Solar UV Radiant Exposures in Spring 2020 on SARS-CoV-2 Viral Inactivation in the UK Rendell R; Khazova M; Higlett M; O'Hagan J Photochem Photobiol; 2021 May; 97(3):542-548. PubMed ID: 33590505 [TBL] [Abstract][Full Text] [Related]
30. Inactivation times from 290 to 315 nm UVB in sunlight for SARS coronaviruses CoV and CoV-2 using OMI satellite data for the sunlit Earth. Herman J; Biegel B; Huang L Air Qual Atmos Health; 2021; 14(2):217-233. PubMed ID: 32952740 [TBL] [Abstract][Full Text] [Related]
31. Solar UV-B/A radiation is highly effective in inactivating SARS-CoV-2. Nicastro F; Sironi G; Antonello E; Bianco A; Biasin M; Brucato JR; Ermolli I; Pareschi G; Salvati M; Tozzi P; Trabattoni D; Clerici M Sci Rep; 2021 Jul; 11(1):14805. PubMed ID: 34285313 [TBL] [Abstract][Full Text] [Related]
32. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
33. Correlation between UV Index, Temperature and Humidity with Respect to Incidence and Severity of COVID 19 in Spain. Pérez-Gilaberte JB; Martín-Iranzo N; Aguilera J; Almenara-Blasco M; de Gálvez MV; Gilaberte Y Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767340 [TBL] [Abstract][Full Text] [Related]
34. The interactive effects of stratospheric ozone depletion, UV radiation, and climate change on aquatic ecosystems. Williamson CE; Neale PJ; Hylander S; Rose KC; Figueroa FL; Robinson SA; Häder DP; Wängberg SÅ; Worrest RC Photochem Photobiol Sci; 2019 Mar; 18(3):717-746. PubMed ID: 30810561 [TBL] [Abstract][Full Text] [Related]
35. Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study. Butler-Laporte G; Nakanishi T; Mooser V; Morrison DR; Abdullah T; Adeleye O; Mamlouk N; Kimchi N; Afrasiabi Z; Rezk N; Giliberti A; Renieri A; Chen Y; Zhou S; Forgetta V; Richards JB PLoS Med; 2021 Jun; 18(6):e1003605. PubMed ID: 34061844 [TBL] [Abstract][Full Text] [Related]
36. The effects of exposure to solar radiation on human health. Neale RE; Lucas RM; Byrne SN; Hollestein L; Rhodes LE; Yazar S; Young AR; Berwick M; Ireland RA; Olsen CM Photochem Photobiol Sci; 2023 May; 22(5):1011-1047. PubMed ID: 36856971 [TBL] [Abstract][Full Text] [Related]
37. UV 254 nm is more efficient than UV 222 nm in inactivating SARS-CoV-2 present in human saliva. Sesti-Costa R; Negrão CVZ; Shimizu JF; Nagai A; Tavares RSN; Adamoski D; Costa W; Fontoura MA; da Silva TJ; de Barros A; Girasole A; de Carvalho M; Teixeira VC; Ambrosio ALB; Granja F; Proença-Módena JL; Marques RE; Dias SMG Photodiagnosis Photodyn Ther; 2022 Sep; 39():103015. PubMed ID: 35843562 [TBL] [Abstract][Full Text] [Related]
38. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Grant WB; Lahore H; McDonnell SL; Baggerly CA; French CB; Aliano JL; Bhattoa HP Nutrients; 2020 Apr; 12(4):. PubMed ID: 32252338 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness and safety of vitamin D in relation to bone health. Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161 [TBL] [Abstract][Full Text] [Related]